Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis. - Wikidata - wikimedia - TriplyDB

Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis.

Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis.

http://www.wikidata.org/entity/Q31139905

about

Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocols Recent advancements in erythrocytes, platelets, and albumin as delivery systems Albumin-based drug delivery: harnessing nature to cure disease Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects.Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics Development of macromolecular prodrug for rheumatoid arthritis Fusion to a highly stable consensus albumin binding domain allows for tunable pharmacokinetics Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy Neonatal Fc receptor: from immunity to therapeutics Genetically based resistance to the antiinflammatory effects of methotrexate in the air-pouch model of acute inflammation Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion.Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain Generation and characterization of small single domain antibodies inhibiting human tumor necrosis factor receptor 1.Albumin binding ligands and albumin conjugate uptake by cancer cells.Intracellular delivery of cytochrome c by galactosylated albumin to hepatocarcinoma cells.Genetically engineered humanized mouse models for preclinical antibody studies.Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts.Particles for Local Delivery of Proteins Using Intra-Articular Route Albumin microspheres as carriers for the antiarthritic drug celecoxib.Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis.Recent advances in intravenous delivery of poorly water-soluble compounds.Antibody-targeted paclitaxel loaded nanoparticles for the treatment of CD20+ B-cell lymphoma.Safety of plasma volume expanders.Native albumin for targeted drug delivery.Using albumin to improve the therapeutic properties of diabetes treatments.Are biological targets the final goal for rheumatoid arthritis therapy?Drug delivery systems: Advanced technologies potentially applicable in personalized treatments.A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis.Methotrexate: a gold standard for treatment of rheumatoid arthritis.Albumin-Oxanorbornadiene Conjugates Formed ex Vivo for the Extended Circulation of Hydrophilic Cargo Recent advances in nanomedicines for the treatment of rheumatoid arthritis.A novel single walled carbon nanotube (SWCNT) functionalization agent facilitating in vivo combined chemo/thermo therapy.Albumin-based micro-composite drug carriers with dual chemo-agents for targeted breast cancer treatment.Schistosomula, pre-adults and adults of Schistosoma mansoni ingest fluorescence-labelled albumin in vitro and in vivo: implication for a drug-targeting model.Albumin-based nanocomposite spheres for advanced drug delivery systems.Factors influencing the antifolate activity of synthetic tea-derived catechins.Cross-species binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding.Development of a novel polyethylene glycol-corticosteroid-conjugate with an acid-cleavable linker.ELPylated anti-human TNF therapeutic single-domain antibodies for prevention of lethal septic shock.

P2860

Q22000845-EE4D8E60-05BE-4673-AD25-C49221237428 Q24793159-667D54E8-31B9-4442-91E3-DEADC2F20DD9 Q26747764-0EBC166A-73DF-41E1-A136-99C4B438E53D Q26765789-BB079AED-B87C-433B-BE75-B9B91F99BFE9 Q26822871-78CE99B5-70F2-474D-8132-64779CDBE3E3 Q27027238-A68DD473-545A-4750-9200-62BA71291392 Q27693332-BEC71AFF-C075-44C7-9F2F-7C6568E4D9DC Q27701821-82D67202-0696-4225-BC44-5AA228B543E0 Q28397980-3BC785AA-4ED0-4A93-818F-299E9E68433A Q34268801-6D56AD04-29CA-481E-857A-CE260C640C90 Q34293811-4D21BFFA-69C7-48B2-AFC7-8DEDADE6D16C Q34420356-BD75E541-EA4C-4036-B7AC-3E68B8286015 Q34724092-FA4150DF-F23E-4882-925E-ECEFA9499EC6 Q35080243-8DC506AB-95C5-4977-B3D4-375CF2F217FE Q35098409-C5C21269-E49D-427B-BF3B-AE28A244E0AB Q35147280-489FC941-9AFE-4783-9110-62DF767E15AD Q35552397-04FDA5A0-C0FF-407D-8335-73A935150308 Q36465510-980A2F74-88E1-434C-B8FF-14D9C5C46309 Q36857699-918AF43A-4497-4E90-A570-F63FD930302A Q37360677-7E72599D-BB4B-4EBA-8944-259AE7AD5CBD Q37453905-618A5CD8-92DA-415C-9870-86B1900AFB4D Q37639306-BB6090BF-9D44-4E50-BB44-0A2F584B82B4 Q37738158-B0FC81FB-FF93-4891-AF0D-1654889558CD Q37760672-81FEB4DA-E657-45ED-AB9E-A6EC087AE723 Q37768453-4FD95002-AD77-439C-8317-8830763EECAA Q37910976-C91F12A8-D91C-406F-AC21-77C46B53A58D Q38041208-6F99780D-18B8-4480-9DA8-8647B8ED0178 Q38063945-F312484E-E41D-4F90-B6A9-73E58B309382 Q38071913-B4E9A79C-03EB-4F63-B9C4-089CE91E8231 Q38260785-0937DF70-7EC5-4C91-8499-10BE254FD313 Q38437371-08995971-C257-4FD9-9E95-7FF8F7273F10 Q38669113-2FB12153-0C2A-4DE5-A501-CA319FE4E8FF Q38847250-FD971BD6-86EC-4150-9C1F-2236064EA120 Q38914616-8BC945FC-1172-4E12-9003-2E6BCC39F96C Q39074566-AEF35E36-004E-4D86-845E-FA26F3238EF0 Q39084294-B6A1AF59-5920-4E44-8ABF-B0CCF0895FCE Q39124465-AA395B4C-D726-4F56-B0A7-DBE78B512851 Q39540318-8A500C65-3C1A-4911-81BB-593BE710F0E2 Q39672742-5B103C03-63BC-4A3B-91B2-433BA0D63E3F Q39707454-EA7AACEE-5AF2-485C-8E6F-579A4CDB2544

P2860

Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis.

http://www.wikidata.org/entity/Q31139905

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis.

@ast

Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis.

@en

type

label

Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis.

@ast

Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis.

@en

prefLabel

Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis.

@ast

Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis.

@en

P1433

Q31139905-D7463044-4D94-468B-B0AD-D0A76CE73394

P1476

Q31139905-3F9F793B-E976-4BE5-BBA7-6235C46428A8

P2093

Q31139905-1FCFDC87-490F-414A-9004-0B5BA61CA702

Q31139905-31B2CEE7-0DFD-42CB-851C-44D1C8CBD733

Q31139905-352FF63C-98CE-4419-BC38-0E10FF01E40F

Q31139905-97A45553-710A-49A2-B433-DE4BA0EFAF37

Q31139905-A0F8CC65-AF2E-4273-AE0D-73E3FB380039

Q31139905-C2D2AE1C-0FC3-494B-A1E0-83613B2BB2B0

Q31139905-CDBEC09E-D5FF-4476-974E-39F3AFBCADC8

Q31139905-D0E75A0F-20DA-4065-96DA-CF01CFA525CF

Q31139905-EF216C48-5971-411C-A125-48273FA14123

P304

Q31139905-8C806337-6428-4AE7-87EF-A0004641DEA1

P31

Q31139905-13B50DF1-FF7E-4AD6-B0FF-C309560FF264

P356

Q31139905-FECF7DDF-4A37-41DC-ADAA-C214F2B433EE

P407

Q31139905-6B61B317-0FF2-4B00-B871-64819FBD392E

P433

Q31139905-E7EA6AD1-625B-4D20-9685-24EC226E81E9

P478

Q31139905-54E0BFFB-7104-474C-A102-92BEC45BF7F7

P50

Q31139905-D05F3AE5-64F1-4E5F-9DF7-06D5F272594E

P577

Q31139905-12FC15A9-DB10-4780-9D11-09C20A174984

P698

Q31139905-1569C833-5766-4F96-9911-E3915A552CC9

P921

Q31139905-7A07506D-3D98-4DBC-A3C2-E7BB0EBC0C15

P356

JIMMUNOL.170.9.4793

P1433

Journal of Immunology

P1476

Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis.

@en

P2093

Andreas Wunder

http://www.w3.org/2001/XMLSchema#string

Christoph Fiehn

http://www.w3.org/2001/XMLSchema#string

Elena Neumann

http://www.w3.org/2001/XMLSchema#string

Ernst H K Stelzer

http://www.w3.org/2001/XMLSchema#string

Gerd Stehle

http://www.w3.org/2001/XMLSchema#string

Hannsjörg Sinn

http://www.w3.org/2001/XMLSchema#string

Jürgen Funk

http://www.w3.org/2001/XMLSchema#string

Steffen Gay

http://www.w3.org/2001/XMLSchema#string

Thomas Pap

http://www.w3.org/2001/XMLSchema#string

P304

4793-4801

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.170.9.4793

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

170

http://www.w3.org/2001/XMLSchema#string

P50

Ulf Müller-Ladner

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12707361

http://www.w3.org/2001/XMLSchema#string

P921